What is the treatment for eczema Herpeticum?
The main treatment of eczema herpeticum is acyclovir, which is also approved for oral use in patients younger than 18 years of age. For patients with severe disease and immunocompromised patients, systemic antivirus medications and hospitalization are recommended.
Is eczema Herpeticum life threatening?
Eczema herpeticum is a potentially life-threatening disease with mortality risk due to complications of systemic viremia, bacteremia, and fungal infection leading to multi-organ failure.
Is eczema Herpeticum curable?
Usually eczema herpeticum is cured by the antiviral medication. Sometimes eczema herpeticum can come back and need to be treated again.
Why is eczema Herpeticum an emergency?
Eczema herpeticum is a medical emergency because it can lead to severe and sometimes life threatening complications, such as: herpetic keratitis, an infection in the cornea of the eye that can lead to vision loss without treatment. organ failure and death, if the virus spreads to the brain, lungs, and liver.
Is eczema Herpeticum an STD?
Eczema herpeticum is a rare, painful skin rash usually caused by the herpes simplex virus (HSV). HSV-1 is the virus that causes cold sores, and it can be transmitted through skin-to-skin contact.
Is eczema Herpeticum an emergency?
Eczema herpeticum, initially described by Kaposi in 1887, is a potentially life-threatening herpetic superinfection of a preexisting skin disease. Despite the availability of antiviral therapies, eczema herpeticum remains a dermatologic emergency today.
How do you describe eczema Herpeticum?
What is eczema herpeticum? Eczema herpeticum is a disseminated viral infection characterised by fever and clusters of itchy blisters or punched-out erosions. It is most often seen as a complication of atopic dermatitis/eczema.
Can a virus trigger eczema?
Skin infections: Bacterial and viral infections of the skin both can bring on eczema flares. Bacteria can secrete toxins into the skin, sparking an immune reaction, which prompts inflammation.